ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.9K
|
647K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.9K
|
647K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
1.9K
|
647K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
1.9K
|
647K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
5 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
1.9K
|
647K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
1.9K
|
647K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
7 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.9K
|
647K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.9K
|
647K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
4 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
2 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
14 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
14
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
4 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
279
|
72K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
279
|
72K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
279
|
72K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
279
|
72K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
279
|
72K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
279
|
72K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
279
|
72K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Anaximines
|
944 |
237K |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
944
|
237K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
279
|
72K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
279
|
72K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
279
|
72K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Piper Alderman investigating Class Action against Isignthis
|
|
Anaximines
|
279 |
72K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
279
|
72K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Anaximines
|
944 |
237K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
944
|
237K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Anaximines
|
944 |
237K |
2 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
944
|
237K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Anaximines
|
944 |
237K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
944
|
237K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
5 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
12 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
12
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
Anaximines
|
1.9K |
647K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
1.9K
|
647K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Treasure Trove
|
|
Anaximines
|
944 |
237K |
0 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
944
|
237K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
2 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC v ISX Hearing
|
|
Anaximines
|
3.3K |
1.0M |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
3.3K
|
1.0M
|
2
|
|